Delivery Order SPE2DB20D9214-SPE2DB24FD4VN

Award Date 8/2/24
Potential Completion Date 8/23/24
Potential Value $8.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,189.60 firm fixed-price delivery order is for the supply of Xolair 150 mg/mL syringes, a specialty biologic medication. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC allows the DLA to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $16,247.70 firm fixed-price delivery order is for the supply of Xolair 150 mg/ml syringes, a specialized biologic medication. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This single-award IDC...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $23,211.00 firm fixed-price delivery order is for the supply of XOLAIR 150 MG/ML SYRINGEML, a specialty pharmaceutical product, with an ultimate completion date of October 15, 2024. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) vehicle under the DLA's SPE2DB program,...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $1,547.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Xolair 150 mg/mL syringes to support the medical supply needs of military health facilities. This delivery order is part of a larger $499,999,999 indefinite-delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a $6,189.60 firm fixed-price delivery order for the supply of Xolair 150 mg/mL syringes, a specialized biologic medication. The contract has an ultimate completion date of February 6, 2025. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $92,844.00 firm fixed-price delivery order is for the supply of XOLAIR 150 MG/ML SYRINGE and has an ultimate completion date of October 31, 2024. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) under the DLA's SPE2DB program, which allows the agency to issue delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,737.00 firm fixed-price delivery order is for the supply of Xolair 150 mg/ml syringes. It is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 with the DLA under the SPE2DB program that allows the agency to issue delivery orders for a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,189.60 firm fixed-price delivery order is for the supply of the drug Xolair 150 mg/ml syringe, with a period of performance through March 1, 2024. The award is part of a larger indefinite delivery contract (IDC) vehicle with DLA under the SPE2DB program, valued at up to $499,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $38,685 firm fixed-price delivery order is for the supply of Xolair 150 mg/mL syringes, a specialized biologic medication. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,377.30 firm fixed-price delivery order is for the supply of Xolair 150 mg/mL syringes, a specialized biologic medication. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) vehicle with the DLA under the SPE2DB program, which allows the agency to issue delivery...
  • SPE2DB20D9214
    Indefinite Delivery Contract
  • SPE2DB20D9214-SPE2DB24FD4VN
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,510.70 firm fixed-price delivery order is for the supply of Xolair 150 mg/mL syringes, a specialized biologic medication.

The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. Through this IDC vehicle, DMS Pharmaceutical Group provides both routine and critical medications to Department of Defense (DoD) healthcare facilities, solidifying the company's position as a crucial supplier in the federal pharmaceutical supply chain.

This particular delivery order does not have a set-aside designation. The contract has an ultimate completion date of August 23, 2024.

Generated 11/1/24, 9:32 AM